Charles River Laboratories ROE - Return on Equity 2010-2024 | CRL

Charles River Laboratories return on equity for the quarter ending September 30, 2024 was 11.46.

  • Charles River Laboratories average return on equity for 2023 was 15.69, a 8.89% decline from 2022.
  • Charles River Laboratories average return on equity for 2022 was 17.22, a 3.48% decline from 2021.
  • Charles River Laboratories average return on equity for 2021 was 17.84, a 3.18% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Charles River Laboratories ROE - Return on Equity 2010-2024 | CRL

  • Charles River Laboratories average return on equity for 2023 was 15.69, a 8.89% decline from 2022.
  • Charles River Laboratories average return on equity for 2022 was 17.22, a 3.48% decline from 2021.
  • Charles River Laboratories average return on equity for 2021 was 17.84, a 3.18% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.